Showing results 1 to 50 of 118
next >
Title Issue Date Author(s) Journal Publisher
Can pioglitazone be potentially useful therapeutically in treating patients with Covid-19? 2020 Carboni, E.; Carta, A. R.; Carboni, E. MEDICAL HYPOTHESES
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species 2020 Carta, A R; Boi, L; Pisanu, A; Palmas, M F; Carboni, E; De Simone, A JOURNAL OF NEUROSCIENCE METHODS
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 2019 Boi, Laura; Pisanu, Augusta; Greig, Nigel; Scerba, Michael T; Tweedie, David; Mulas, Giovanna; Fe...nu, Sandro; Carboni, Ezio; Spiga, Saturnino; Carta, Anna R MOVEMENT DISORDERS
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats 2019 Jadzic, Dragana; Bassareo, Valentina; Carta, Anna R; Carboni, Ezio ADDICTION BIOLOGY
Enhanced limbic/impaired cortical-loop connection onto the hippocampus of NHE rats: Application of resting-state functional connectivity in a preclinical ADHD model 2017 Zoratto, F; Palombelli, Gm; Ruocco, La; Carboni, Ezio; Laviola, G; Sadile, Ag; Adriani, W; Canese..., R. BEHAVIOURAL BRAIN RESEARCH
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 2016 Mulas, Giovanna; Espa, Elena; Fenu, Sandro; Spiga, Saturnino; Cossu, Giovanni; Pillai, Elisabetta...; Carboni, Ezio; Simbula, Gabriella; Jadžić, Dragana; Angius, Fabrizio; Spolitu, Stefano; Batetta, Barbara; Lecca, Daniela; Giuffrida, Andrea; Carta, Annarosa EXPERIMENTAL NEUROLOGY
Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine 2016 Cadeddu, Roberto; Jadzic, Dragana; Carboni, Ezio EUROPEAN NEUROPSYCHOPHARMACOLOGY
Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum 2015 Ruocco, LA; Treno, C; Gironi Carnevale, UA; Arra, C; Boatto, G; Pagano, C; Tino, A; Nieddu, M; Mi...chel, M; Prikulis, I; Carboni, E; De Souza Silva, MA; Huston, JP; Sadile, AG; Korth, C AMINO ACIDS
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 2015 Melis, Miriam; Carboni, Ezio; Caboni, Pierluigi; Acquas, ELIO MARIA GIOACHINO ADDICTION BIOLOGY
Differential sensitivity of ethanol-elicited ERK phosphorylation in nucleus accumbens of Sardinian alcohol-preferring and -non preferring rats 2014 Rosas, M; Zaru, A; Sabariego, M; Giugliano, V; Carboni, E; Colombo, G; Acquas, E. ALCOHOL
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? 2014 Cadeddu R; Ibba M; Sadile A; Carboni E PSYCHOPHARMACOLOGY
Long term effects of adolescent chronic mild stress on brain catecholamine transmission in rat brain: a microdialysis study 2014 Cadeddu, Roberto; Ibba, M; Schirru, C; Carboni, Ezio
Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface 2014 Ruocco LA; Treno C; Gironi Carnevale UA; Arra C; Boatto G; Nieddu M; Pagano C; Illiano P; Barbato... F; Tino A; Carboni E; Laviola G; Lacivita E; Leopoldo M; Adriani W; Sadile AG PLOS ONE
Different classes of antidepressants share the ability to increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: A possible role in antidepressant therapy? 2013 CARBONI E; CADEDDU R
Different classes of antidepressants increase dopamine and norepinephrine release in the bed nucleus of stria terminalis: an “in vivo” microdialysis study 2013 Carboni E; Ibba M; Cadeddu R
Increase of dopamine and norepinephrine release in the bed nucleus of stria terminalis: a common feature of antidepressants? 2013 Cadeddu R; Ibba M; Carboni E
The MPTP/probenecid model of progressive Parkinson's disease. 2013 Carta, Annarosa; Carboni, Ezio; Spiga, Saturnino Humana Press - Springer
Role of prefrontal cortex dopamine and noradrenaline circuitry in addiction 2012 Carboni, Ezio; Cadeddu, Roberto; Carta, Annarosa InTech Web Org
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 2011 Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E. NEUROSCIENCE
The alpha 7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2011 Carboni E; Ibba M; Cadeddu R; Hogenkamp D; Johnstone T; Gee KW BIOCHEMICAL PHARMACOLOGY
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2011 CARTA AR; PISANU A; FRAU L; SPIGA S; CARBONI E International brain resesearch organization
The α7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain 2011 CARBONI E; IBBA M; CADEDDU R; HOGENKAMP D; JOHNSTONE T; GEE KW SOC. NEUROSCI. ABSTR., 41TH ANNUAL MEETING SOCIETY FOR NEUROSCIENCE, WASHINGTON D.C., 12-16 NOVEMBRE 2011
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 2011 CARTA A; PISANU A; FRAU L; SPIGA S; CARBONI E SOC. NEUROSCI. ABSTR., 41TH ANNUAL MEETING SOCIETY FOR NEUROSCIENCE, WASHINGTON D.C., 12-16 NOVEMBRE 2011 Society for Neuroscience
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 2011 Carta AR; Pisanu A; Carboni E PARKINSON'S DISEASE
Gender specific reduction of hypermotility by sub-chronic methylphenidate or atomoxetine in SH rats, an animal model of ADHD 2010 IBBA M; SIMOLA N; COSSEDDU S; CARBONI E MONITORING MOLECULES IN NEUROSCIENCE Vrije Universiteit
PRENATAL RESTRAINT STRESS: AN IN VIVO MICRODIALYSIS STUDY ON CATECHOLAMINE RELEASE IN THE RAT PREFRONTAL CORTEX 2010 CARBONI E; BARROS VG; IBBA M; SILVAGNI A; MURA C; ANTONELLI MC NEUROSCIENCE
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. 2010 Fumagalli F; Cattaneo A; Caffino L; Ibba M; Racagni G; Carboni E; Gennarelli M; Riva MA PHARMACOLOGICAL RESEARCH
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2010 CARTA A; FENU S; FRAU L; IBBA M; WARDAS J; CABONI P; CARBONI E SOCIETY FOR NEUROSCIENCE Society for Neurosciences
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats 2010 RUOCCO LA; CARNEVALE UA; TRENO C; SADILE AG; MELISI D; ARRA C; IBBA M; SCHIRRU C; CARBONI E BEHAVIOURAL BRAIN RESEARCH
Effects of sub-chronic methylphenidate and atomoxetine on noradrenaline and dopamine transmission in the prefrontal cortex of adolescent SH rats, an animal model of ADHD 2010 IBBA M; CARBONI E MONITORING MOLECULES IN NEUROSCIENCE Vrije Universiteit
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 2009 SCHINTU N; FRAU L; IBBA M; CABONI P; GARAU A; CARBONI E; CARTA AR EUROPEAN JOURNAL OF NEUROSCIENCE
Chronic methylphenidate or atomoxetine treatment alters BDNF expression in the brain of spontaneously hypertensive rats 2009 Cattaneo A; Caffino L; Sesta A; Ibba M; Carboni E; Fumagalli F; Riva MA; Gennarelli M EUROPEAN NEUROPSYCHOPHARMACOLOGY
METHYLPHENIDATE AND ATOMOXETINE AFFECT BDNF EXPRESSION IN THE BRAIN OF SPONTANEOUS HYPERTENSIVE RATS. 2009 Caffino L; Cattaneo A; Ibba M; Sesta A; Racagni G; Carboni E; Gennarelli M; Riva AM; Fumagalli F SOCIETY FOR NEUROSCIENCE
DIFFERENT EFFECTS OF METHYLPHENIDATE AND ATOMOXETINE ON BDNF EXPRESSION IN THE BRAIN OF SPONTANEOULSY HYPERTENSIVE RATS 2009 CATTANEO AM; IBBA M; RACAGNI G; CARBONI E; GENNARELLI M; RIVA MA; FUMAGALLI F SOCIETY FOR NEUROSCIENCE
52) Carboni E., Ibba M., Schirru C., Sadile A. (2009). BEHAVIORAL AND NEUROCHEMICAL CHANGES INDUCED BY METHYLPHENIDATE OR ATOMOXETINE SUB-CHRONIC TREATMENT IN ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR) ARE GENDER SPECIFIC 2009 CARBONI E; IBBA M; SCHIRRU C; SADILE A SOCIETY FOR NEUROSCIENCE
PREPUBERAL SUBCHRONIC METHYLPHENIDATE AND ATOMOXETINE INDUCE DIFFERENTIAL LONG TERM EFFECTS ON ADULT BEHAVIOR AND FOREBRAIN DOPAMINE, NOREPINEPHRINE AND SEROTONIN IN NAPLES HIGH EXCITABILITY RATS 2009 SADILE A; RUOCCO L.A; GIRONI CARNEVALE U.A; TRENO C; CONTE R; ARRA C; IBBA M; SCHIRRU C; CARBONI E SOCIETY FOR NEUROSCIENCE
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2009 SCHINTU N; FRAU L; IBBA M; GARAU A; CARBONI E; CARTA AR NEUROTOXICITY RESEARCH
THE INTERRELATIONSHIP OF DOPAMINE AND NORADRENALINE IN THE PREFRONTAL CORTEX : FROM PHYSIOOLGY TO THERAPY 2009 Carboni, Ezio; Carta, Annarosa NOVA SCIENCE PUBLISHERS
PROGRESSIVE DECLINE OF BEHAVIORAL AND BIOCHEMICAL PARAMETERS IN THE CHRONIC MPTP/PROBENECID MOUSE MODEL OF PARKINSON’S DISEASE. 2008 Carta A; Schintu N; Frau L; Ibba M; Carboni E SOCIETY FOR NEUROSCIENCE
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 2008 RUOCCO LA; VIGGIANO D; PIGNATELLI M; IANNACCONE T; RIMOLI MG; MELISI D; CURCIO A; DE LUCIA S; CAR...BONI E; CARNEVALE UA; DE CAPRARIIS P; SADILE AG BEHAVIOURAL BRAIN RESEARCH
PPAR-GAMMA RECEPTOR AGONIST PREVENTS NEURODEGENERATION AND BEHAVIOURAL DEFICITS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON’S DISEASE. 2008 Frau L; Schintu N; Carboni E; Ibba M; Carta AR SOCIETY FOR NEUROSCIENCE
CHRONIC TREATMENT WITH METHYLPHENIDATE OR ATOMOXETINE DETERMINES CHANGES OF NORADRENARGIC AND DOPAMINERGIC TRANSMISSION IN THE PREFRONTAL CORTEX OF ADOLESCENT SPONTANEOUS HYPERTENSIVE RATS (SHR): A MICRODIALYSIS STUDY. 2008 Carboni E; Silvagni A; Ibba M; Sadile A; Di Chiara G
DOPAMINERGIC NEUROTRANSMISSION IN A RAT MODEL OF PRENATAL STRESS 2008 Katunar MR; Adrover E; Barros V; Saez T; Silvagni A; Brusco A; Carboni E; Antonelli MC SOCIETY FOR NEUROSCIENCE
Prenatal restraint stress differentially modifies basal and stimulated dopamine and noradrenaline release in the nucleus accumbens shell: an 'in vivo' microdialysis study in adolescent and young adult rats. 2008 Silvagni A; Barros VG; Mura C; Antonelli MC; Carboni E EUROPEAN JOURNAL OF NEUROSCIENCE
Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats. 2008 Ruocco LA; Viggiano D; Viggiano A; Abignente E; Rimoli MG; Melisi D; Curcio A; Nieddu M; Boatto G...; Carboni E; Gironi Carnevale UA; Sadile AG. NEUROSCIENCE
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 2008 FRAU L; SCHINTU N; CARBONI E; SILVAGNI A; CARTA AR
Naples high excitability and spontaneously hypertensive model different variants of attention-deficit hyperactivity disorder 2007 VIGGIANO D; VALLONE D; RUOCCO A; CARBONI E; GIRONI UA; CARNEVALE; SADILE AG SOCIETY FOR NEUROSCIENCE
Antidepressants, dose dependently, increase dopamine and norepinephrine extracellular concentration in rat bed nucleus of stria terminalis: a microdialysis study 2007 CARBONI E; SILVAGNI A; MURA C; DI CHIARA G SOCIETY FOR NEUROSCIENCE
CAFFEINE AND ACCUMBENS SHELL DOPAMINE 2006 De Luca MA; Carboni E; Bassareo V; Cauli O; Bauer A; Di Chiara G SOCIETY FOR NEUROSCIENCE
42) Carboni E, Silvagni A, Barros VG, Di Chiara G. (2006). BASAL AND AMPHETAMINE STIMULATED DOPAMINE AND NORADRENALINE TRANSMISSION IN RAT BRAIN ARE DIFFERENTIALLY AFFECTED BY PRENATAL STRESS: AN IN VIVO MICRODIALYSIS STUDY. 2006 Carboni E; Silvagni A; Barros VG; Di Chiara G. Federation of Eropean Neuroscience Societies

Questionnaire and social

Share on: